Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
Midbrain dopaminergic neurons generated from stem cells show promise for the treatment of Parkinson’s disease. Here, the authors use the cell surface marker, LRTM1, to enrich the midbrain dopaminergic progenitors and show improved motor function/cell survival when grafted into rat/monkey brains, res...
Guardado en:
Autores principales: | Bumpei Samata, Daisuke Doi, Kaneyasu Nishimura, Tetsuhiro Kikuchi, Akira Watanabe, Yoshimasa Sakamoto, Jungo Kakuta, Yuichi Ono, Jun Takahashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72b25ae7a986456d8a439b751da50607 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
por: Aaron M. Earley, et al.
Publicado: (2021) -
MHC matching improves engraftment of iPSC-derived neurons in non-human primates
por: Asuka Morizane, et al.
Publicado: (2017) -
16p11.2 deletion is associated with hyperactivation of human iPSC-derived dopaminergic neuron networks and is rescued by RHOA inhibition in vitro
por: Maria Sundberg, et al.
Publicado: (2021) -
Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis.
por: Diogo Ribeiro, et al.
Publicado: (2011) -
Robust detection of undifferentiated iPSC among differentiated cells
por: Keisuke Sekine, et al.
Publicado: (2020)